PMID- 23280964 OWN - NLM STAT- MEDLINE DCOM- 20130918 LR - 20211108 IS - 1552-485X (Electronic) IS - 1552-4841 (Linking) VI - 162B IP - 2 DP - 2013 Mar TI - Refinement of chromosome 3p22.3 region and identification of a susceptibility gene for bipolar affective disorder. PG - 163-8 LID - 10.1002/ajmg.b.32127 [doi] AB - Genome-wide association studies and meta-analysis, as well as our own previous family-based association results, have pointed to chromosome (ch) 3p22.3 and 3p21.1 as candidate regions to contain a susceptibility gene for bipolar affective disorder (BPAD). In the present study, we further refined the region of interest on ch 3p22.3. We genotyped 94 SNPs within the candidate region in 74 families and performed family-based association analysis using a transmission disequilibrium test. One single SNP (rs166508) was associated with the BPAD phenotype (P = 0.0187). This SNP is located within intron 15 of the integrin alpha 9 (ITGA9) gene. ITGA9 encodes the alpha9 subunit of the alpha9beta1 integrin, a membrane glycoprotein receptor for neurotrophins, such as nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF). Quantification of ITGA9 transcripts in the peripheral blood of patients with BPAD and controls showed an upregulation of ITGA9 (Kruskal-Wallis P = 0.0339) in patients with the disease-associated genotype (rs166508*A/A), compared to those with rs166508*G/G and rs166508*G/A genotypes. Sequencing of the ITGA9 cDNA revealed a sequence variant (r.1689_1839del) in rs166508*A carriers, which leads to loss of the entire exon 16. In silico analysis revealed that the deleted region contains three putative microRNA binding sites, which may be involved in the negative regulation of ITGA9. In conclusion, our results confirm previous evidence pointing to a candidate region for BPAD on ch 3p.22.3. In addition, we suggest a molecular substrate that could explain the increase of ITGA9 mRNA levels in probands with BPAD, proposing a new mechanism that could be involved in the genetic susceptibility to the disease. CI - Copyright (c) 2012 Wiley Periodicals, Inc. FAU - Secolin, Rodrigo AU - Secolin R AD - Department of Medical Genetics, University of Campinas-UNICAMP, Campinas, SP, Brazil. FAU - Banzato, Claudio E M AU - Banzato CE FAU - Mella, Lucas F B AU - Mella LF FAU - Santos, Marilza L AU - Santos ML FAU - Dalgalarrondo, Paulo AU - Dalgalarrondo P FAU - Lopes-Cendes, Iscia AU - Lopes-Cendes I LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20121231 PL - United States TA - Am J Med Genet B Neuropsychiatr Genet JT - American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics JID - 101235742 RN - 0 (DNA, Complementary) RN - 0 (ITGA9 protein, human) RN - 0 (Integrins) RN - 0 (RNA, Messenger) SB - IM MH - Base Sequence MH - Bipolar Disorder/*genetics MH - Chromosomes, Human, Pair 3/*genetics MH - DNA, Complementary/genetics MH - Gene Expression Regulation MH - Gene Frequency/genetics MH - *Genetic Association Studies MH - *Genetic Predisposition to Disease MH - Humans MH - Integrins/genetics/metabolism MH - Molecular Sequence Data MH - Polymorphism, Single Nucleotide/genetics MH - RNA, Messenger/genetics/metabolism EDAT- 2013/01/03 06:00 MHDA- 2013/09/21 06:00 CRDT- 2013/01/03 06:00 PHST- 2011/10/28 00:00 [received] PHST- 2012/12/07 00:00 [accepted] PHST- 2013/01/03 06:00 [entrez] PHST- 2013/01/03 06:00 [pubmed] PHST- 2013/09/21 06:00 [medline] AID - 10.1002/ajmg.b.32127 [doi] PST - ppublish SO - Am J Med Genet B Neuropsychiatr Genet. 2013 Mar;162B(2):163-8. doi: 10.1002/ajmg.b.32127. Epub 2012 Dec 31.